Concepedia
Publication | Open Access
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)
53
Citations
17
References
2024
Year
Page 1